Genetic Technologies financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$4.71M $9.54M $10.63M $15.29M $3.92M $5.38M $4.92M $4.59M $3.69M $3.38M $4.56M $2.01M $0.82M $0.52M $0.19M $0.03M $0.01M $0.12M $9.61M $10.35M $0.00M
GM % Gross Margin %
75.31% 77.07% 93.53% 96.21% 77.30% 38.56% -35.21% -33.46% 12.86% -28.67% 36.09% 34.06% 9.89% 5.03% -58.56% 0.00% 87.89% -199.47% 68.66% 58.10% 0.00%
OM Operating Margin
-201.37% -118.36% -73.60% -16.57% -94.10% -165.36% -206.00% 22.80% -298.55% -276.16% -223.73% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -68.48% -100.66% 0.00%
EPS Earnings Per Share
$0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
0m 296.81m 362.39m 362.39m 362.39m 374.64m 374.64m 404.61m 464.61m 474.97m 572.69m 848.6m 1715.28m 2435.28m 2435.28m 2644.12m 4063.13m 82.62m 92.34m 92.34m 115.42m
OCF Operating Cash Flow
$-5.28M $-5.79M $-5.96M $2.60M $0.42M $-4.92M $-4.30M $2.23M $-7.67M $-7.52M $-10.99M $-9.69M $-7.73M $-6.81M $-5.64M $-6.07M $-5.71M $-6.30M $-5.66M $-9.72M $0.00M
FCF Free Cash Flow
$-6.08M $-6.41M $-6.12M $2.44M $0.30M $-5.13M $-4.44M $2.09M $-7.75M $-7.57M $-11.04M $-9.88M $-8.03M $-7.04M $0.00M $-6.12M $-5.75M $-7.05M $-5.72M $-9.74M $0.00M
FCFS Free Cash Flow Per Share
$-0.02 $-0.02 $-0.02 $0.01 $0.00 $-0.01 $-0.01 $0.01 $-0.02 $-0.02 $-0.02 $-0.01 $-0.00 $-0.00 $-0.00 $-0.00 $-0.00 $-0.00 $-0.00 $-0.10 $0.00